NEWS!!!Eight additional licences in Kyrgyz Republic Securedhttp://sa.iguana2.com/cache/c594f3b8530685b29f583570f344d6b3/ASX-CIG-318580.pdf
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%